Healthcare research multiple myeloma - analysis in patient referring physician and participation satisfaction concerning the interdisciplinary CCF MM-tumorboard.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00008573

Enrollment

100

Registered

2015-05-21

Start date

2014-03-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C90.0

Interventions

Group 1: Tumor boards (TB) have become a crucial institution in oncology practice. They ensure paramount interdisciplinary cancer treatment according to clinical pathways, continues cancer education a

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with multiple myeloma

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Evaluate the satisfaction of MM-Patients with standardized questionnaires at the moment of indication of therapy.	—

Countries

Germany

Contacts

Public ContactMonika Engelhardt Engelhardt

Uniklinik Freiburg

monika.engelhardt@uniklinik-freiburg.de+49 761 270 32460

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026